Vaxil BioTherapeutics
Developing Cancer and Tuberculosis Vaccines
Active
Mature
Startup
Ness Ziona
Founded 2007-02
Vaxil BioTherapeutics is a clinical-stage company developing immunotherapeutic products, including long peptide vaccines and antibodies to treat cancer and infectious diseases. Vaxils products are derived from its fully owned proprietary technology, VaxHit, which uses the signal peptide domains in selected targets as core antigens. The companys lead product…
SectorHealth Tech & Life Sciences
StageMature
Total raised$6.0M
Employees4
Founded2007-02
HQNess Ziona
Crunchbasevaxil-biotherapeutics
Patents1
Confidence93
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development
Technology
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology